|
Video Games Controlled By Player's Breath May Help Clear Airway Of Cystic Fibrosis Patients
|
|
Scritto da Cystic Fibrosis News From Medical News Today |
 Video games controlled by the player's breath can encourage youths with cystic fibrosis to use techniques that can help keep their airways clearer, according to a study to be presented Saturday, April 30, at the Pediatric Academic Societies (PAS) an ... ...
|
|
|
All Women Should Be Offered Cystic Fibrosis Screening, Regardless Of Ethnicity
|
|
Scritto da Cystic Fibrosis News From Medical News Today |
 Preconception and prenatal cystic fibrosis (CF) carrier screening should be made available to all women of reproductive age as a routine part of obstetric care, according to a revised Committee Opinion issued by The American College of Obstetricians ... ...
|
|
Phase 3 Study Of VX-770 Shows Marked Improvement In Lung Function Among People With Cystic Fibrosis With G551D Mutation
|
|
Scritto da Cystic Fibrosis News From Medical News Today |
 The Cystic Fibrosis Foundation and Vertex Pharmaceuticals announced that VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis, showed promising results in a Phase 3 clinical trial. The trial was desig ... ...
|
|
Breakthrough On Cystic Fibrosis One Step Closer As New Research Alliance Formed
|
|
Scritto da Cystic Fibrosis News From Medical News Today |
 McGill University and GlaxoSmithKline plc (GSK) have signed a collaboration agreement to develop a potential breakthrough approach to treat cystic fibrosis, a fatal genetic disease... ... ...
|
|
|
Mpex Initiates Phase 3 Clinical Trial Program With Aeroquin For The Treatment Of Chronic Bacterial Infections In Cystic Fibrosis Patients
|
|
Scritto da Cystic Fibrosis News From Medical News Today |
 Mpex Pharmaceuticals, Inc. during the JP Morgan 29th Annual Healthcare Conference, announced that it has initiated its Phase 3 clinical trial program with Aeroquin? (MP-376) for the treatment of pulmonary infections in patients with cystic fibrosis ( ... ...
|
|
Inspire Announces Results Of Second Phase 3 Trial With Denufosol For Cystic Fibrosis
|
|
Scritto da Cystic Fibrosis News From Medical News Today |
 Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced the top-line results from its second Phase 3 clinical trial, TIGER-2, with denufosol tetrasodium for the treatment of cystic fibrosis (CF)... ... ...
|
|
Novel Drug Offers Hope For Early Intervention In Cystic Fibrosis Patients
|
|
Scritto da Cystic Fibrosis News From Medical News Today |
 Cystic fibrosis (CF) patients with normal to mildly impaired lung function may benefit from a new investigational drug designed to help prevent formation of the sticky mucus that is a hallmark of the disease, according to researchers involved in a ... ...
|
|
|
Inizio Prec. 1 2 3 4 5 6 7 8 9 10 Succ. > Fine >>
|
| Pag 3 di 14 |
